Open for inclusion

A Phase II, single arm, multicenter trial to determine the efficacy and safety of CTL019 in pediatric patients with relapsed or refractory B-cell acute lymphoblastic leukemia

Cancer type: Leukemia

Phase: II

Principal Investigator: Büchner Jochen

Country: NO

Keywords: Norway, Oslo, Pediatric, CTL019 and acute lymphoblastic leukemia

Status: Open for inclusion

Link to